Tollys earns ‘Best-in-class therapeutic innovation’ award from MATWIN for its drug candidate TL-532

Confirmation by MATWIN’s panel of scientific and industry experts of therapeutic potential of TL-532 major boost for Tollys, supports moving flagship product towards clinical phase